Form 4 for INDP Indaptus Therapeutics, Inc.

Accepted 2022-02-02 00:00:00 ET · period of report 2022-01-31 · accession 0001493152-22-003002 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X	Filed	Traded	Ticker	Insider	Title	Type	Price	Qty	Owned	ΔOwn	Value
MI	2022-02-02	2022-01-31+	INDP	Newman Michael James	CSO, Dir, 10%	S - Sale	$5.00	-20.0K	1.37M	-1%	-$100.0K

Purchase Sale Sale after option exercise All abbreviations

#	Table	Security	Date	Code	A/D	Shares	Price	Owned after	Own	Exercise / expiry	Underlying	Footnotes
1	Common	Common Stock	2022-01-31	S	D	5,870	$5.00	1,382,486	I See footnote	—	—	(F1) The sale of shares of common stock reported on this Form 4 was made pursuant to a Rule 10b5-1 trading plan adopted on December 13, 2021. (F2) Consists of (i) 1,355,654 shares of common stock held by the Michael J. Newman Trust, dated January 21, 2008, Michael J. Newman, Trustee, and (ii) 26,832 shares of common stock held by his spouse Janet Lee Harris, Trustee of the Janet Harris Living Trust, executed on March 25, 2009.
2	Common	Common Stock	2022-02-01	S	D	14,130	$5.00	1,368,356	I See footnote	—	—	(F1) The sale of shares of common stock reported on this Form 4 was made pursuant to a Rule 10b5-1 trading plan adopted on December 13, 2021. (F3) Consists of (i) 1,341,524 shares of common stock held by the Michael J. Newman Trust, dated January 21, 2008, Michael J. Newman, Trustee, and (ii) 26,832 shares of common stock held by his spouse Janet Lee Harris, Trustee of the Janet Harris Living Trust, executed on March 25, 2009.